MedTrace Logo

Worm Study: Modifier Genes in Sudden Cardiac Death

NCT02014961 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 223

Last updated 2015-05-14

No results posted yet for this study

Summary

Quest for modifier genes associated with ventricular arrhythmias in presence of a cardiac sodium channel gene (SCN5A-delPhe1617) mutation.

Conditions

  • Brugada Syndrome
  • Long QT Syndrome 3

Interventions

PROCEDURE

Dermal biopsy

Skin biopsy

BEHAVIORAL

Gastro-intestinal questionnaire

Pagi-Sym, Bristol Stool Chart, gastrointestinal symptom rating scale (GSRS)

GENETIC

Whole-exome sequencing

Whole-exome sequencing (WES)

Sponsors & Collaborators

  • Netherlands Heart Foundation

    collaborator OTHER

  • Maastricht University Medical Center

    lead OTHER

Principal Investigators

  • Paul Volders, M.D., Ph.D. · Maastricht University Medical Centre

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2025-04-30
Completion
2025-04-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02014961 on ClinicalTrials.gov